FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years
GSK announced that the company's vaccine for protection against mumps, measles, and rubella (MMR) had been approved by the U.S. FDA. According to data from six clinical studies, the company filed a Biologics License Application in August 2021.
GSK's MMR vaccine first met with regulatory approval in 1997, when the biologic was approved for marketing in Germany. Since then, it has been approved in every European country and Canada, Australia, and New Zealand. Clinical trials included approximately 17,000 participants from each vaccination age group (12 to 15 months, 4 to 6 years old, and over seven...
